These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38699798)

  • 21. Management of patients receiving antithymocyte globulin for aplastic anemia and myelodysplastic syndrome.
    Bevans MF; Shalabi RA
    Clin J Oncol Nurs; 2004 Aug; 8(4):377-82. PubMed ID: 15354924
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe aplastic anaemia--complete response to antilymphocyte globulin and cyclosporin.
    Jones-Lecointe A; Murphy A; Charles W; Daisley H; Pitt-Miller P
    West Indian Med J; 1999 Dec; 48(4):238-9. PubMed ID: 10639849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of aplastic anaemia with lower-dose anti-thymocyte globulin produces similar response rates and survival as per standard dose anti-thymocyte globulin schedules.
    Scott A; Morris K; Butler J; Mills AK; Kennedy GA
    Intern Med J; 2016 Oct; 46(10):1198-1203. PubMed ID: 27404498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete remission of severe aplastic anaemia following treatment with anti-thymocyte globulin.
    Griffin M; Coffey L; McCann SR
    Ir J Med Sci; 1983 Aug; 152(8):313-5. PubMed ID: 6605326
    [No Abstract]   [Full Text] [Related]  

  • 25. Acute kidney injury with extreme hyperuricemia after antithymocyte globulin treatment in a kidney transplant recipient with underlying aplastic anemia: a case report.
    Park Y; Chung BH; Park CW; Kim YS; Yang CW
    BMC Nephrol; 2020 Jul; 21(1):251. PubMed ID: 32615929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of severe aplastic anaemia with anti-thymocyte globulin.
    McCann SR; Sullivan F; Reynolds M; Temperley IJ
    Acta Haematol; 1985; 74(3):144-7. PubMed ID: 3938158
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.
    Frickhofen N; Heimpel H; Kaltwasser JP; Schrezenmeier H;
    Blood; 2003 Feb; 101(4):1236-42. PubMed ID: 12393680
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery from aplastic anemia after treatment with antilymphocyte globulin.
    Silingardi V; Torelli U
    Arch Intern Med; 1979 May; 139(5):582-3. PubMed ID: 443953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation of posaconazole versus fluconazole or itraconazole in the prevention of invasive fungal infection in high-risk neutropenic patients in Sweden.
    Lundberg J; Höglund M; Björkholm M; Åkerborg Ö
    Clin Drug Investig; 2014 Jul; 34(7):483-9. PubMed ID: 24820968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus-induced polyclonal lymphoproliferative disorder of lymphoplasmacytic type in an autopsy case of aplastic anemia treated twice with anti-thymocyte globulin therapy.
    Okada E; Shigeyasu H; Inaguma Y; Emi N; Sano K; Tsutsumi Y
    Pathol Int; 2015 May; 65(5):274-6. PubMed ID: 25677466
    [No Abstract]   [Full Text] [Related]  

  • 31. Micafungin versus posaconazole prophylaxis in acute leukemia or myelodysplastic syndrome: A randomized study.
    Epstein DJ; Seo SK; Huang YT; Park JH; Klimek VM; Berman E; Tallman MS; Frattini MG; Papanicolaou GA
    J Infect; 2018 Sep; 77(3):227-234. PubMed ID: 29746955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human leucocyte antigen-matched related haematopoietic stem cell transplantation using low-dose cyclophosphamide, fludarabine and thymoglobulin in children with severe aplastic anaemia.
    Alsultan A; Abujoub R; Alsudairy R; Memon S; Jarrar MS; Alafghani S; Aldaama S; Ballourah W; Almanjomi F; Essa MF
    Br J Haematol; 2023 Oct; 203(2):255-263. PubMed ID: 37491781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Aplastic anemia: from children to adults].
    Kojima S; Hama A
    Rinsho Ketsueki; 2013 Aug; 54(8):721-5. PubMed ID: 24005431
    [No Abstract]   [Full Text] [Related]  

  • 34. [Pathogenesis and treatment of myelodysplastic syndromes and hypoplastic anemia].
    Gavrilov OK; Terent'reva OV
    Klin Med (Mosk); 1990 Aug; 68(8):23-6. PubMed ID: 2084365
    [No Abstract]   [Full Text] [Related]  

  • 35. Anti-lymphocyte globulin therapy in aplastic anaemia--a university hospital experience.
    Leong KW; Teh A; Bosco JJ; Jayaranee S; Sadat U
    Med J Malaysia; 1995 Jun; 50(2):158-61. PubMed ID: 7565186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of Jurkat cell-reactive anti-T lymphocyte globulin and fetal anti-thymocyte globulin preparations in the treatment of aplastic anemia.
    Serefhanoglu S; Buyukasik Y; Purnak T; Goker H; Sayinalp N; Haznedaroglu IC; Ozcebe OI
    Med Princ Pract; 2011; 20(4):341-4. PubMed ID: 21576994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of fungal disease in the setting of neutropenia.
    Walsh TJ; Gamaletsou MN
    Hematology Am Soc Hematol Educ Program; 2013; 2013():423-7. PubMed ID: 24319214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Addition of anti-thymocyte globulin to standard graft-versus-host disease prophylaxis versus standard treatment alone in patients with haematological malignancies undergoing transplantation from unrelated donors: final analysis of a randomised, open-label, multicentre, phase 3 trial.
    Walker I; Panzarella T; Couban S; Couture F; Devins G; Elemary M; Gallagher G; Kerr H; Kuruvilla J; Lee SJ; Moore J; Nevill T; Popradi G; Roy J; Schultz KR; Szwajcer D; Toze C; Foley R;
    Lancet Haematol; 2020 Feb; 7(2):e100-e111. PubMed ID: 31958417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A case of thymoma showing significant tumor reduction after anti-thymocyte globulin.
    Hayashida H; Honda A; Hino T; Mizuno H; Toyama K; Kurokawa M
    Gen Thorac Cardiovasc Surg; 2022 Jan; 70(1):96-99. PubMed ID: 34709554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thymocyte globulin treatment of a patient for paroxysmal nocturnal haemoglobinuria-aplastic anaemia syndrome: complement activation and transient decrease of the PNH clone.
    Ebenbichler CF; Würzner R; Sandhofer AD; Niederwieser D; Dierich MP; Patsch JR
    Immunobiology; 1996-1997; 196(5):513-21. PubMed ID: 9145329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.